Oncology Institute Inc.
TOI | NASDAQ
$5.13
-$1.26 (-19.72%)
At close: Aug 03, 2026, 04:00 PM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 587.24M | 545.76M | 502.73M | 461.04M | 424.38M | 403.15M | 393.41M | 378.93M | 361.07M | 342.71M | 324.24M | 309.88M | 292.82M | 273.51M | 252.48M | 233.36M | 220.66M | 209.58M | 203M | 199.67M | 194.64M | 192.08M |
Cost of Revenue | 362.58M | 464.88M | 426.29M | 392.73M | 360.62M | 343.88M | 339.42M | 325.19M | 305.72M | 285.27M | 264.67M | 249.05M | 234.97M | 219.64M | 200.39M | 188.57M | 177.44M | 166.62M | 162.16M | 157.1M | 153.92M | 152.76M |
Gross Profit | 63.38M | 80.89M | 76.44M | 68.31M | 63.75M | 59.28M | 54M | 53.74M | 55.35M | 57.44M | 59.57M | 60.82M | 57.85M | 53.87M | 52.09M | 44.8M | 43.22M | 42.97M | 40.85M | 42.57M | 40.72M | 39.32M |
Operating Income | -26.09M | -32.69M | -36.08M | -41.11M | -46.9M | -52.06M | -60.12M | -63.48M | -63.55M | -62.12M | -77.02M | -86.81M | -92.98M | -96.35M | -81.95M | -97.7M | -79.76M | -62.58M | -45.86M | -10.01M | -8.56M | -7.31M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 940K | 1.97M | 3.18M | 3.18M | 2.24M | 1.21M | n/a | n/a | n/a | n/a | n/a | n/a | 73.39K | 73.39K |
Pretax Income | -36.29M | -43.64M | -60.74M | -66.41M | -66.02M | -64.36M | -64.66M | -70.55M | -71.72M | -73.04M | -83.1M | -75.41M | -60.82M | -49.51M | -91K | -1.34M | -824K | 8.65M | -11.6M | -3.99M | -2.51M | -5.44M |
Net Income | -36.29M | -43.51M | -60.61M | -66.28M | -65.89M | -64.36M | -64.66M | -70.24M | -71.54M | -72.96M | -83.07M | -75.32M | -60.58M | -49.13M | 152K | 1M | 697K | 9.36M | -10.93M | -5.59M | -3.29M | -5.47M |
Selling & General & Admin | 111.45M | 81.5M | 78.67M | 75.49M | 50.23M | 50.23M | 24.86M | n/a | n/a | n/a | n/a | n/a | 31.96M | 60.31M | 90.12M | 138.36M | 119.13M | 101.99M | 83.37M | 50.16M | 37.43M | 34.76M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 139.31M | 32.07M | 33.85M | 33.93M | 60.42M | 61.1M | 89.26M | 117.22M | 118.9M | 119.57M | 136.59M | 147.63M | 118.86M | 89.91M | 43.93M | 4.14M | 3.86M | 3.55M | 3.34M | 2.42M | 11.86M | 11.86M |
Operating Expenses | 250.76M | 113.57M | 112.52M | 109.41M | 110.66M | 111.33M | 114.12M | 117.22M | 118.9M | 119.57M | 136.59M | 147.63M | 150.83M | 150.22M | 134.04M | 142.5M | 122.98M | 105.54M | 86.71M | 52.58M | 49.28M | 46.62M |
Interest Expense | 7.63M | 7.64M | 11.28M | 10.53M | 10.83M | 11.08M | 7.5M | 8.27M | 8.74M | 9.29M | 9.96M | 10.47M | 9.27M | 6.66M | 4.08M | 1.69M | 273K | 293K | 320K | 486.88K | 408.88K | 438.63K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 11.2M | 11.2M | 11.2M | 11.2M | n/a | n/a |
Cost & Expenses | 447.44M | 578.45M | 538.81M | 502.14M | 471.28M | 455.21M | 453.53M | 442.41M | 424.62M | 404.84M | 401.26M | 396.68M | 385.8M | 369.86M | 334.43M | 331.07M | 300.43M | 272.16M | 248.86M | 209.67M | 203.2M | 199.38M |
Income Tax Expense | n/a | -131K | -131K | -131K | -131K | n/a | n/a | -314K | -179K | -80K | -36K | -89K | -248K | -379K | -243K | -2.34M | -1.52M | -709K | -671K | 1.6M | 779.81K | 29.02K |
Shares Outstanding (Basic) | 1.03B | 1.02B | 1.01B | 974.75M | 932.04M | 77.1M | 75.66M | 75.52M | 74.75M | 74.23M | 73.47M | 73.47M | 74.12M | 73.45M | 72.75M | 79.58M | 73M | 73.25M | 69.95M | 74.59M | 66.02M | 66.02M |
Shares Outstanding (Diluted) | 1.03B | 1.02B | 1.01B | 974.75M | 932.04M | 77.1M | 75.66M | 75.52M | 74.75M | 74.23M | 73.47M | 73.47M | 74.12M | 73.45M | 85.59M | 79.58M | 73M | 76.25M | 69.95M | 74.59M | 66.02M | 66.02M |
EPS (Basic) | -0.28 | -0.35 | -0.54 | -0.64 | -0.68 | -0.70 | -0.71 | -0.78 | -0.79 | -0.85 | -1.04 | -0.96 | -0.80 | -0.65 | -0.02 | -0.04 | -0.04 | 0.08 | -0.16 | -0.31 | -0.35 | -0.38 |
EPS (Diluted) | -0.28 | -0.35 | -0.54 | -0.64 | -0.68 | -0.70 | -0.71 | -0.78 | -0.79 | -0.85 | -1.04 | -0.94 | -0.78 | -0.63 | -0.01 | -0.05 | -0.05 | 0.07 | -0.16 | -0.31 | -0.35 | -0.38 |
EBITDA | -18.54M | -29.23M | -42.52M | -48.86M | -48.32M | -46.7M | -50.88M | -54.4M | -54.27M | -55.98M | -54.29M | -55.11M | -42.99M | -33.77M | 1.49M | 4.49M | 3.3M | 12.49M | -7.94M | -429K | 905.25K | -2M |
EBIT | -20.73M | -36M | -49.46M | -55.88M | -55.19M | -53.28M | -57.17M | -60.55M | -60.55M | -62.07M | -60.17M | -60.6M | -47.92M | -38.46M | -2.92M | 351K | -551K | 8.94M | -11.28M | -3.64M | -2.25M | -5.16M |
Depreciation & Amortization | 6.81M | 6.78M | 6.94M | 7.02M | 6.87M | 6.58M | 6.29M | 6.16M | 6.28M | 6.09M | 5.87M | 5.49M | 4.92M | 4.69M | 4.41M | 4.14M | 3.86M | 3.55M | 3.34M | 3.21M | 3.15M | 3.16M |
Add to Watchlist
Select watchlists to add or remove TOI